Indivior Initiates $175M Accelerated Share Repurchase Under Existing Program
INDV has more than doubled off its 52-week low of $10.63.
Summary
Indivior announced a $175 million accelerated share repurchase, initiating a substantial portion of its existing $400 million buyback program.
Key Events · Financing and Capital Events · INDV
-
Accelerated Share Repurchase Agreement
Indivior entered into an ASR agreement with an investment bank to repurchase $175 million of its common stock.
-
Initial Share Delivery
The company received an initial delivery of 3,717,473 shares upon payment of the $175 million prepayment amount.
-
Part of Existing Program
This ASR is part of the previously announced $400 million share repurchase program, with $100 million remaining for future repurchases.
-
Expected Completion
The ASR transaction is expected to be completed by June 22, 2026, with the final number of shares based on the volume-weighted average price less a discount.
Analysis · INDV · Life Sciences
This filing details Indivior's entry into a $175 million Accelerated Share Repurchase (ASR) agreement, executing a significant portion of its previously authorized $400 million share repurchase program. The ASR demonstrates the company's confidence in its financial strength and commitment to returning capital to shareholders, following strong Q1 2026 results. This action is expected to reduce the outstanding share count, potentially boosting earnings per share.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INDV was trading at $37.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $10.63 to $40.02. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.